Farzin Fath-Ordoubadi

Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial

Abizaid A, Kedev S, Kedhi E, Talwar S, Erglis A, Hlinomaz O, Masotti M, Fath-Ordoubadi F, Lemos P, Milewski K, Botelho R, Costa R, Bangalore S

December 7, 2018 | 10.4244/EIJ-D-18-00762

Forward and back aspiration during ST-elevation myocardial infarction: a feasibility study

Farooq V, Serruys P, Mustafa A, Mamas MA, Malik N, Alhous H, El-Omar M, Hendry C, Rana D, Shelton D, Wright P, Narine N, Clarke B, Keavney B, Fath-Ordoubadi F, Fraser D

April 8, 2016 | 10.4244/EIJV11I14A315

Serial optical coherence tomography of drug-eluting stent in-stent restenosis treated with the Absorb bioresorbable scaffold: an effective treatment?

Farooq V, Mamas MA, Frase D, El-Omar M, Clarke B, Fath-Ordoubadi F

March 20, 2015 | 10.4244/EIJV10I11A224

Minimising radial injury: prevention is better than cure

Mamas MA, Fraser D, Ratib K, Fath-Ordoubadi F, El-Omar M, Nolan J, Neyses L

November 20, 2014 | 10.4244/EIJV10I7A142

Thrombus capture by withdrawal of an open filter device: a useful treatment for large non-occlusive coronary thrombus

Arnous S, Agelaki M, Shakhshir N, Kelly D, Ordoubadi F, Mamas MA, Fraser D

October 20, 2014 | 10.4244/EIJV10I6A120

Lessons from acute and late scaffold failures in the ABSORB EXTEND trial: have we really learned them all?

Farooq V, Fraser D, El-Omar M, Mamas MA, Clarke B, Fath-Ordoubadi F

August 19, 2014 | 10.4244/EIJV10I4A73

Longitudinal stent deformation: a retrospective analysis of frequency and mechanisms

Williams P, Mamas MA, Morgan K, El-Omar M, Clarke B, Bainbridge A, Fath-Ordoubadi F, Fraser D

June 27, 2012 | 10.4244/EIJV8I2A41

Coronary perforation in the drug-eluting stent era: incidence, risk factors, management and outcome: the UK experience

Hendry C, Fraser D, Eichhöfer J, Mamas MA, Fath-Ordoubadi F, El-Omar M, Williams P

May 15, 2012 | 10.4244/EIJV8I1A13

Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study

Danzi G, Chevalier B, Urban P, Fath-Ordoubadi F, Carrié D, Wiemer M, Serra A, Wijns W, Kala P, Stabile A, Ruigomez J, Sagic D, Laanmets P, Strupp G, West N, Paunovic D

May 15, 2012 | 10.4244/EIJV8I1A17

Use of the Sideguard (Cappella) stent in bifurcation lesions: a real-world experience

Mamas MA, Farooq V, Latib A, Sastry S, D’souza S, Williams P, Wiper A, Neyses L, El-Omar M, Fraser D, Fath-Ordoubadi F

February 21, 2012 | 10.4244/EIJV7I10A188

Late outcomes of drug eluting and bare metal stents in saphenous vein graft percutaneous coronary intervention

Nair S, Fath-Ordoubadi F, Clarke B, El-Omar M, Foley J, Fraser D, Mahadevan V, Neyses L, Khattar R, Mamas MA

March 21, 2011

Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice

Appleby C, Khattar R, Morgan K, Clarke B, Curzen N, Neyses L, Fath-Ordoubadi F

January 20, 2011

Use of the Heartrail II catheter as a distal stent delivery device; an extended case series

Mamas MA, Eichhofer E, Hendry C, El-Omar M, Clarke B, Neyses L, Fath-Ordoubadi F, Fraser D

June 30, 2009 | 10.4244/EIJV5I2A41

The role of thrombectomy and distal protection devices during percutaneous coronary interventions

Mamas MA, Fraser D, Fath-Ordoubadi F

May 13, 2008

Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial

Chevalier B, Serruys P, Silber S, Garcia E, Suryapranata H, Hauptmann K-E, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley S, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D

February 20, 2007

Adjunctive Antiplatelet / Antithrombotic therapy in percutaneous coronary intervention

Eichhöfer J, Fraser D, Fath-Ordoubadi F

November 20, 2005

Farzin Fath-Ordoubadi

Latest news